Episode 29: Asia’s 2025 Q2 Report: Global Trends in Biopharma Transactions
During the Asia-focused Episode 29 of Biotalk, Geoff shares insights into key trends and developments shaping the biotech landscapes in Japan, China, Korea, Australia, and the broader Asia-Pacific re…
Biotalk Episode 28: 2025 Q2 Report: Global Trends in Biopharma Transactions
During Episode 28 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q2 Report: Global Trends in Biopharma Transactions Report, covering capital markets, strategic deals, and regional t…
Episode 27: Inside the Biopharma Market: 2025 Outlook & Emerging Trends
During Episode 27 of Biotalk, Geoff Meyerson, CEO of Locust Walk, steps back to examine the macro forces shaping the biopharma landscape. After holding a bearish outlook since 2021, Geoff explains wh…
Episode 26: Asia’s 2025 Q1 Report: Global Trends in Biopharma Transactions
During the Asia-focused Episode 26 of Biotalk, Geoff Meyerson, CEO of Locust Walk, shares fresh insights from Japan, China, and Korea, as featured in our 2025 Q1 Report: Global Trends in Biopharma Tr…
Biotalk Episode 25: 2025 Q1 Report: Global Trends in Biopharma Transactions
During Episode 25 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q1 Report: Global Trends in Biopharma Transactions Report, covering capital markets, strategic deals, and regional t…
Biotalk Episode 24: Asia’s 2024 Year-In-Review
During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, explores the evolving biotech landscapes in Japan and China, highlighting key trends and developments shaping the region as feature…
Biotalk Episode 23: 2024 Year-In-Review Report: Global Trends in Biopharma Transactions
During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2024 Year-In-Review Report: Global Trends in Biopharma Transactions Report. Geoff dives into the insights from the comp…
Biotalk Episode 22: A Conversation with Sudhir Agrawal of ARNAY Sciences
On this episode of Biotalk, Geoff Meyerson, CEO and Co-founder of Locust Walk, speaks with Sudhir Agrawal, Founder and President of ARNAY Sciences and a pioneer in RNA therapeutics. Sudhir’s extensiv…
Biotalk Episode 21: Analyzing the 2024 U.S. Election’s Impact on Biotech
In this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, is joined by Andy Meyerson, Managing Director, and Daniel Brog, Senior Vice President, for an insightful discussion on the implications…
Biotalk Episode 20: A Conversation with David Harel of CytoReason
On this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, sits down with David Harel, CEO and Co-founder of CytoReason. CytoReason uses AI-powered disease models to transform drug discovery and…
Biotalk Episode 19: 2024 Q3 Report: Global Trends in Biopharma Transactions
Biotalk Episode 18: A Conversation with Lindsay Rosenwald of Fortress Biotech
On this episode of Biotalk, Locust Walk’s Andy Meyerson welcomes Dr. Lindsay Rosenwald, Chairman, President and Chief Executive Officer of Fortress Biotech, a company focused on licensing and develop…
Biotalk Episode 17: Q2 2024 Report: Global Trends in Biopharma Transactions
Biotalk Episode 16: A Conversation with Stephen Sands of Lazard
Biotalk Episode 15: 2024 Q1 Report: Global Trends in Biopharma Transactions
During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2024 Q1 Report: Global Trends in Biopharma Transactions Report. Each quarter, Locust Walk’s deal team compiles key stat…
Biotalk Episode 14: A Conversation with Kendalle Burlin O’Connell of MassBio
On this episode of Biotalk, Locust Walk’s Geoff Meyerson welcomes Kendalle Burlin O’Connell, Esq., CEO and President of MassBio, the nation’s pioneering biotechnology trade association, which plays a…
Biotalk Episode 13: 2023 Year-In-Review Report: Global Trends in Biopharma Transactions
Biotech capital markets: XBI performance and IPO volume
Private biotech markets: Financin…
Biotalk Episode 12: A Conversation with Soufiane Aboulhouda of Nucleate
On this episode of Biotalk, Locust Walk‘s Geoff Meyerson welcomes Soufiane Aboulhouda, Co-Founder and Chairman of the Board of Nucleate, a global non-profit dedicated to empowering future biotech lea…
Biotalk Episode 11: A Conversation with Shehnaaz Suliman of ReCode Therapeutics